Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2764-2026

MEDLINE medical procedure convenience kit labeled as: HIP CDS-LF, Medline kit SKU CDS984556N Recall

MEDLINE medical procedure convenience kit labeled as: HIP CDS-LF, Medline kit SKU CDS984556N

FDA recall Class I

Ongoing

FDA lists this Class I recall for MEDLINE medical procedure convenience kit labeled as: HIP CDS-LF, Medline kit SKU CDS984556N. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2764-2026
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Jun 8, 2026
FDA report date
Jul 29, 2026
Quantity in commerce
52 kits
Distribution
See key details
FDA cause
Nonconforming Material/Component

What is being recalled?

MEDLINE medical procedure convenience kit labeled as: HIP CDS-LF, Medline kit SKU CDS984556N

Affected model & UDI checker

Search the exact identifiers published for Z-2764-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedMEDLINE medical procedure convenience kit labeled as: HIP CDS-LF, Medline kit SKU CDS984556NCheck source notice10198459266621
Not specifiedMEDLINE medical procedure convenience kit labeled as: HIP CDS-LF, Medline kit SKU CDS984556NCheck source notice40198459266622
FDA code information

UDI/DI 10198459266621 (each) 40198459266622 (case), Lot Numbers: 26EDA285, 26DDA718, 26BDB740, 26ADB079, 26ADA161, 25KDB472, 25GDA213.

View the original FDA recall notice

Why was this product recalled?

The procedure kits contain ICU Medical, Inc. pain management kits containing Bupivacaine Hydrochloride in Dextrose Injection, USP, which were recalled due to quality issues that could result in drug ineffectiveness.

These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.

What actions did Medline Industries, LP take?

Medline Industries, LP issued an URGENT MEDICAL DEVCIE RECALL notice to its consignees on 6/8/2026 via email and USPS first class mail. The notice explained the issue and requested the following actions be taken: 1. Check stock and quarantine all affected product. 2. Use Website link: https://recalls.medline.com to respond. 3. Once response is received, Medline will send over-labels to affix to affected inventory (if applicable). 4. If the consignee further distributed or transferred the affected product, those to whom the product was sent are to be notified. For questions, contact the Recall Department at 866-359-1704 or [email protected].

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA classification recorded

  3. FDA notice posted

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology